Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Patient Educ Couns. 2019 Apr 9;102(9):1636–1643. doi: 10.1016/j.pec.2019.04.012

Table 3.

Frequency and Examples of Initial Chemotherapy-Induced Peripheral Neuropathy (CIPN) Assessment Question Types Asked by Clinicians to Participants (N = 44)

Characteristic of CIPN Discussion Frequency (%) Quotes
Asked participant about numbness AND/OR tingling without reference to their extremities 16 (36%)

  1. So, the peripheral neuropathy, the numbness and tingling?

  2. Any numbness or tingling?

  3. Still no tingling?
Asked participant about numbness AND tingling in both their upper and lower extremities 11 (25%)

  1. Any numbness or tingling in your fingers or toes?

  2. Do you have numbness or tingling in your hands or feet
Asked participant about numbness OR tingling in either their upper OR lower extremities alone 10 (23%)

  1. Tingling in fingers or toes?

  2. Any numbness in your fingers?
Asked about neuropathy in general 4 (9%)

  1. Any neuropathy?

  2. It looks like you had some questions regarding the neuropathy…
Other 3 (7%)

  1. Any hand-problems

  2. Any issues with the mouth sores or co Id-sensitivity